Pendal Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-343
Closed -$735K 492
2018
Q2
$735K Buy
+343
New +$735K 0.01% 339